European Archives - Page 5 of 1121 - European Medical Journal

Clinical Insights in Rheumatology

In this three-part series, Jonathan Sackier sits down with Richard Conway, rheumatologist, researcher, and educator. Together, they delve into cutting-edge insights on polymyalgia rheumatica, immune ageing, and the future of rheumatology care.

Oral Nutraceutical Shows Promise for Treating Acne

A study has shed new light on a novel approach to managing acne vulgaris, highlighting the efficacy of an oral nutraceutical.

Breaking Barriers in Tuberculosis: Interview with Dirk Schnappinger

Dirk Schnappinger – Professor of Microbiology and Immunology, Weill Cornell Medical College, New York City, USA – Your lab has developed…

mCRPC Evolving Treatment Landscape

This is a non-promotional medical symposium funded and organised by Bayer. This presentation contains information on products, indications or combinations that are not licensed in all countries, or not licensed in any region. Please consult your local prescribing information for more information. This content is intended for healthcare professionals only.

Food Addiction and Taste Bud Rehab: Interview with David Katz

David Katz | Chief Medical Officer, Tangelo, Intend; Founder/CEO, DietID, Detroit, Michigan, USA. What initially sparked your interest in…

5 minutes with... Andrew Cooper, CEO, CluePoints

Discover Andrew Cooper’s passion for optimising clinical trials with AI, driving innovation and building a culture of teamwork and purpose.

Invasive E. coli Disease Risk After Urological Procedures

The study aimed to assess the risk of IED following urologic procedures with or without antibiotic prophylaxis.

New Muscle Reference Values Improve Sarcopenia Screening

Researchers have established standardised global cutoffs for skeletal muscle index and density on abdominal CT in healthy young adults, aiding early sarcopenia detection.

Joan Carles

Onc Now: Episode 17: Breaking New Ground in Genitourinary Cancer Treatment

Joan Carles, Vall d’Hebron, shares insights on anti-angiogenic therapies, resistance in GU cancers, and the future of personalised oncology.

Mental Health Decline Observed in Metabolic Disease Patients Post-Pandemic

A recent study utilizing UK Biobank data has identified a significant rise in new-onset mental health disorders—specifically depression, anxiety, and alcohol use disorders—among adults with metabolic diseases such as hypertension, diabetes, and obesity in the aftermath of the COVID-19 pandemic.